Benefit of Combination Ezetimibe/Simvastatin Among High-Risk Populations: Lessons from the IMPROVE-IT Trial
W Oliver, Robert P. Giugliano
Topics & Concepts
EzetimibeMedicineInternal medicineHazard ratioSimvastatinStatinClinical endpointRelative riskPlaceboPCSK9CardiologyClinical trialConfidence intervalCholesterolLipoproteinLDL receptorAlternative medicinePathologyLipoproteins and Cardiovascular HealthCancer, Lipids, and MetabolismDiabetes, Cardiovascular Risks, and Lipoproteins